higenamine has been researched along with cucurbitacin b in 1 studies
| Studies (higenamine) | Trials (higenamine) | Recent Studies (post-2010) (higenamine) | Studies (cucurbitacin b) | Trials (cucurbitacin b) | Recent Studies (post-2010) (cucurbitacin b) |
|---|---|---|---|---|---|
| 136 | 4 | 70 | 176 | 0 | 130 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, R; Chen, D; Hao, J; He, JH; Jin, ZQ; Li, X; Liang, J; Liu, D; Mao, Y; Wu, XZ; Yang, X; Yuan, JW | 1 |
1 other study(ies) available for higenamine and cucurbitacin b
| Article | Year |
|---|---|
Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase 2; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Protein Interaction Domains and Motifs; Proto-Oncogene Mas; Proto-Oncogene Proteins c-akt; Signal Transduction; Tetrahydroisoquinolines; Trichosanthes; Triterpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |